BKA
PFE icon

Brick & Kyle Associates’s Pfizer PFE Stock Holding History

Brick & Kyle Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,823
Closed -$269K – 59
2020
Q3 		$269K Buy
+7,823
New +$274K 0.19% 55
2019
Q4 		– Sell
-8,011
Closed -$283K – 66
2019
Q3 		$283K Sell
8,011
-185
-2% -$6.73K 0.23% 55
2019
Q2 		$338K Sell
8,196
-2,077
-20% -$82.5K 0.32% 49
2019
Q1 		$414K Buy
10,273
+858
+9% +$34.4K 0.42% 44
2018
Q4 		$390K Buy
+9,415
New +$391K 0.37% 59
2018
Q2 		$330K Sell
9,591
-1,732
-15% -$59.2K 0.26% 74
2018
Q1 		$381K Sell
11,323
-414
-4% -$14.2K 0.31% 69
2017
Q4 		$403K Buy
11,737
+138
+1% +$4.71K 0.33% 70
2017
Q3 		$393K Buy
11,599
+8
+0.1% +$257 0.32% 68
2017
Q2 		$369K Buy
11,591
+50
+0.4% +$1.58K 0.32% 69
2017
Q1 		$375K Sell
11,541
-397
-3% -$12.5K 0.29% 71
2016
Q4 		$368K Buy
11,938
+8
+0.1% +$244 0.3% 69
2016
Q3 		$383K Buy
11,930
+78
+0.7% +$2.61K 0.31% 69
2016
Q2 		$396K Buy
11,852
+110
+0.9% +$3.51K 0.32% 67
2016
Q1 		$330K Buy
11,742
+9
+0.1% +$257 0.29% 69
2015
Q4 		$359K Buy
11,733
+218
+2% +$6.86K 0.32% 66
2015
Q3 		$343K Buy
11,515
+1,261
+12% +$40.4K 0.32% 67
2015
Q2 		$326K Buy
10,254
+6
+0.1% +$196 0.27% 77
2015
Q1 		$338K Buy
10,248
+443
+5% +$14.1K 0.29% 75
2014
Q4 		$290K Buy
+9,805
New +$281K 0.25% 79

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Brick & Kyle Associates's PFE Position: Q4 2020 in Review

Brick & Kyle Associates sold out of Pfizer (PFE) in Q4 2020, closing a stake of 7,823 shares — an estimated $269K sold.

Brick & Kyle Associates first reported a position in PFE in Q4 2014 and held it in 20 quarters. The position peaked at $414K in Q1 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Brick & Kyle Associates reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Brick & Kyle Associates sold 7,823 Pfizer shares in Q4 2020, an estimated $269K.
  • Brick & Kyle Associates first reported a position in Pfizer in Q4 2014 and held it in 20 quarters.
  • Brick & Kyle Associates's Pfizer position peaked at $414K in Q1 2019.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Brick & Kyle Associates's 13F filing for Q4 2020, filed 16 Feb 2021.